BREAKING NEWS

Now Reading:

Wrinkle free deal as boxtox maker accepts Actavis takeover bid


corporate

Wrinkle free deal as boxtox maker accepts Actavis takeover bid

Botox producer Allergan has accepted a $66 bn takeover bid by Actavis.

The deal ends a nine-month pursuit of Allergan by the Canadian company Valeant Pharmaceuticals.

Dublin-based Actavis offered cash and shares way above the amount Valeant put on the table.

It marks a victory for Allergan, who fought the Valeant bid in court claiming the Canadian drugmaker has a history of cutting research and development spending at companies it acquires.

Every story can be told in many ways: see the perspectives from Euronews journalists in our other language teams.

Next Article

corporate

Pfizer pays top dollar to buy into Merck's anti-cancer research